- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 7/06 - Inactivation or attenuationProducing viral sub-units by chemical treatment
Patent holdings for IPC class C12N 7/06
Total number of patents in this class: 130
10-year publication summary
|
3
|
6
|
9
|
8
|
7
|
10
|
7
|
13
|
3
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Valneva Austria GmbH | 115 |
9 |
| Valneva | 47 |
5 |
| Bharat Biotech International Limited | 89 |
4 |
| Serum Institute of India Private Limited | 101 |
4 |
| ACP Japan Co., Ltd. | 74 |
3 |
| Seqirus UK Limited | 429 |
3 |
| Shionogi & Co., Ltd. | 850 |
3 |
| Takeda Vaccines, Inc. | 222 |
3 |
| Resilience Government Services, Inc. | 27 |
3 |
| Bayer HealthCare LLC | 1351 |
2 |
| National Institute of Advanced Industrial Science and Technology | 3792 |
2 |
| Novozymes A/S | 3325 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1371 |
2 |
| Elanco US Inc. | 727 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2861 |
2 |
| University of Georgia Research Foundation, Inc. | 1032 |
2 |
| Adcure Biotechnologies, LLC. | 3 |
2 |
| Solventum Intellectual Properties Company | 3333 |
2 |
| Boehringer Ingelheim International GmbH | 4645 |
1 |
| EMD Millipore Corporation | 651 |
1 |
| Other owners | 73 |